{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:14:10Z","timestamp":1794244450750,"version":"4.9.0"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T00:00:00Z","timestamp":1682812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T00:00:00Z","timestamp":1682812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>COVID-19 infections are known to cause numerous systemic complications including cardiovascular disorders. In this regard, clinicians recently noticed that patients recovering from COVID-19 infections presented with diverse set of cardiovascular disorders in addition to those admitted to ICU (intensive care unit). COVID-19 heart has multifaceted presentation ranging from dysrhythmias, myocarditis, stroke, coronary artery disease, thromboembolism to heart failure. Atrial fibrillation is the most common cardiac arrhythmia among COVID-19 patients. In the background section, we briefly discussed epidemiology and spectrum of cardiac arrhythmias in COVID-19 patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main body<\/jats:title><jats:p>In this state-of-the-art review we present here, we present the information regarding COVID-19-induced A-fib in sections, namely mechanism of action, clinical presentation, diagnosis and treatment. Unfortunately, its occurrence significantly increases the mortality and morbidity with a potential risk of complications such as cardiac arrest and sudden death. We included separate sections on complications including thromboembolism and ventricular arrhythmias. Since its mechanism is currently a gray area, we included a separate section on basic science research studies that are warranted in the future to comprehend its underlying pathogenic mechanisms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Taken together, this review builds upon the current literature of COVID-19-induced A-fib, including pathophysiology, clinical presentation, treatment and complications. Furthermore, it provides recommendations for future research moving forward that can open avenues for developing novel remedies that can prevent as well as hasten clinical recovery of atrial fibrillation in COVID-19 patients.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s43044-023-00359-0","type":"journal-article","created":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T14:01:43Z","timestamp":1682863303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["COVID-19\u00a0HEART unveiling as atrial fibrillation: pathophysiology, management and future directions for research"],"prefix":"10.1186","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0442-1489","authenticated-orcid":false,"given":"Sri Harsha","family":"Kanuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prapthi","family":"Jayesh Sirrkay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse Sena","family":"Ulucay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,30]]},"reference":[{"issue":"4","key":"359_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.hrthm.2021.01.018","volume":"18","author":"SE Mountantonakis","year":"2021","unstructured":"Mountantonakis SE, Saleh M, Fishbein J et al (2021) Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection. Heart Rhythm 18(4):501\u2013507","journal-title":"Heart Rhythm"},{"issue":"1","key":"359_CR2","doi-asserted-by":"publisher","first-page":"12014","DOI":"10.1038\/s41598-022-16113-6","volume":"12","author":"J Wollborn","year":"2022","unstructured":"Wollborn J, Karamnov S, Fields KG, Yeh T, Muehlschlegel JD (2022) COVID-19 increases the risk for the onset of atrial fibrillation in hospitalized patients. Sci Rep 12(1):12014","journal-title":"Sci Rep"},{"issue":"5","key":"359_CR3","doi-asserted-by":"publisher","first-page":"e010666","DOI":"10.1161\/CIRCEP.121.010666","volume":"15","author":"AG Rosenblatt","year":"2022","unstructured":"Rosenblatt AG, Ayers CR, Rao A et al (2022) New-onset atrial fibrillation in patients hospitalized with COVID-19: results from the American Heart Association COVID-19 Cardiovascular Registry. Circ Arrhythmia Electrophysiol 15(5):e010666","journal-title":"Circ Arrhythmia Electrophysiol"},{"issue":"7","key":"359_CR4","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.recesp.2020.12.014","volume":"74","author":"A Uribarri","year":"2021","unstructured":"Uribarri A, N\u00fa\u00f1ez-Gil IJ, Aparisi \u00c1 et al (2021) Atrial fibrillation in patients with COVID-19. Usefulness of the CHA(2)DS(2)-VASc score: an analysis of the international HOPE COVID-19 registry. Rev Esp Cardiol (Engl Ed) 74(7):608\u2013615","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"12","key":"359_CR5","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1001\/jama.2022.2411","volume":"327","author":"J Abbasi","year":"2022","unstructured":"Abbasi J (2022) The COVID heart\u2014one year after SARS-CoV-2 infection, patients have an array of increased cardiovascular risks. JAMA 327(12):1113\u20131114","journal-title":"JAMA"},{"key":"359_CR6","first-page":"100631","volume":"30","author":"M Gawa\u0142ko","year":"2020","unstructured":"Gawa\u0142ko M, Kap\u0142on-Cie\u015blicka A, Hohl M, Dobrev D, Linz D (2020) COVID-19 associated atrial fibrillation: incidence, putative mechanisms and potential clinical implications. Int J Cardiol Heart Vasc 30:100631","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"12","key":"359_CR7","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1136\/heartjnl-2022-320845","volume":"108","author":"P Raatikainen","year":"2022","unstructured":"Raatikainen P, Lassila R (2022) COVID-19: another reason for anticoagulation in patients with atrial fibrillation. Heart 108(12):902\u2013904","journal-title":"Heart"},{"issue":"3","key":"359_CR8","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/joa3.12718","volume":"38","author":"Y Yuniadi","year":"2022","unstructured":"Yuniadi Y, Yugo D, Fajri M et al (2022) ECG characteristics of COVID-19 patient with arrhythmias: referral hospitals data from Indonesia. J Arrhythmia 38(3):432\u2013438","journal-title":"J Arrhythmia"},{"issue":"12","key":"359_CR9","doi-asserted-by":"publisher","first-page":"e0244533","DOI":"10.1371\/journal.pone.0244533","volume":"15","author":"JH Cho","year":"2020","unstructured":"Cho JH, Namazi A, Shelton R et al (2020) Cardiac arrhythmias in hospitalized patients with COVID-19: a prospective observational study in the western United States. PLoS ONE 15(12):e0244533","journal-title":"PLoS ONE"},{"issue":"9","key":"359_CR10","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.hrthm.2020.06.016","volume":"17","author":"A Bhatla","year":"2020","unstructured":"Bhatla A, Mayer MM, Adusumalli S et al (2020) COVID-19 and cardiac arrhythmias. Heart Rhythm 17(9):1439\u20131444","journal-title":"Heart Rhythm"},{"issue":"19","key":"359_CR11","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/eurheartj\/ehaa388","volume":"41","author":"RM Inciardi","year":"2020","unstructured":"Inciardi RM, Adamo M, Lupi L et al (2020) Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J 41(19):1821\u20131829","journal-title":"Eur Heart J"},{"key":"359_CR12","doi-asserted-by":"publisher","first-page":"720129","DOI":"10.3389\/fcvm.2021.720129","volume":"8","author":"Z Li","year":"2021","unstructured":"Li Z, Shao W, Zhang J et al (2021) Prevalence of atrial fibrillation and associated mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis. Front Cardiovasc Med 8:720129","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"359_CR13","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.jacep.2021.02.009","volume":"7","author":"DR Musikantow","year":"2021","unstructured":"Musikantow DR, Turagam MK, Sartori S et al (2021) Atrial fibrillation in patients hospitalized with COVID-19. JACC Clin Electrophysiol 7(9):1120\u20131130","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"359_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40520-021-02008-5","volume":"34","author":"S Fumagalli","year":"2022","unstructured":"Fumagalli S, Trevisan C, Del Signore S et al (2022) Atrial fibrillation and COVID-19 in older patients: how disability contributes to shape the risk profile. An analysis of the GeroCovid registry. Aging Clin Exp Res 34(1):249\u2013256","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"359_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.hroo.2022.10.012","volume":"4","author":"HM Bernstein","year":"2023","unstructured":"Bernstein HM, Paciotti B, Srivatsa UN (2023) Incidence and implications of atrial fibrillation in patients hospitalized for COVID compared to non-COVID pneumonia: a multicenter cohort study. Heart Rhythm O2 4(1):3\u20138","journal-title":"Heart Rhythm O2"},{"issue":"2","key":"359_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.37616\/2212-5043.1255","volume":"33","author":"A Abdulrahman","year":"2021","unstructured":"Abdulrahman A, Hussain T, Nawaz S et al (2021) Is atrial fibrillation a risk factor for worse outcomes in severe COVID-19 patients: a single center retrospective cohort. J Saudi Heart Assoc 33(2):160\u2013168","journal-title":"J Saudi Heart Assoc"},{"key":"359_CR17","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.hrthm.2020.05.001","volume":"17","author":"B Siripanthong","year":"2020","unstructured":"Siripanthong B, Nazarian S, Muser D et al (2020) Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm 17:1463\u20131471","journal-title":"Heart Rhythm"},{"key":"359_CR18","doi-asserted-by":"publisher","first-page":"951314","DOI":"10.3389\/fcvm.2022.951314","volume":"9","author":"N Voleti","year":"2022","unstructured":"Voleti N, Reddy SP, Ssentongo P (2022) Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: a systematic review and meta-analysis. Front Cardiovasc Med 9:951314","journal-title":"Front Cardiovasc Med"},{"key":"359_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/JIR.S10095","volume":"3","author":"HA Hadi","year":"2010","unstructured":"Hadi HA, Alsheikh-Ali AA, Mahmeed WA, Suwaidi JA (2010) Inflammatory cytokines and atrial fibrillation: current and prospective views. J Inflamm Res 3:75\u201397","journal-title":"J Inflamm Res"},{"issue":"33","key":"359_CR20","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1093\/eurheartj\/ehab314","volume":"42","author":"\u00d2 Mir\u00f3","year":"2021","unstructured":"Mir\u00f3 \u00d2, Jim\u00e9nez S, Mebazaa A et al (2021) Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome. Eur Heart J 42(33):3127\u20133142","journal-title":"Eur Heart J"},{"issue":"17","key":"359_CR21","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1136\/heartjnl-2020-317355","volume":"106","author":"M Pagnesi","year":"2020","unstructured":"Pagnesi M, Baldetti L, Beneduce A et al (2020) Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19. Heart 106(17):1324\u20131331","journal-title":"Heart"},{"key":"359_CR22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3390\/jcdd9090292","volume":"9","author":"Y Zhan","year":"2022","unstructured":"Zhan Y, Yue H, Liang W, Wu Z (2022) Effects of COVID-19 on arrhythmia. J Cardiovasc Dev Dis 9:292","journal-title":"J Cardiovasc Dev Dis"},{"issue":"5","key":"359_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41577-022-00714-3","volume":"22","author":"PE Lazzerini","year":"2022","unstructured":"Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL (2022) Inflammatory cytokines and cardiac arrhythmias: the lesson from COVID-19. Nat Rev Immunol 22(5):270\u2013272","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"359_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.hroo.2022.01.002","volume":"3","author":"MP Lavelle","year":"2022","unstructured":"Lavelle MP, Desai AD, Wan EY (2022) Arrhythmias in the COVID-19 patient. Heart Rhythm O2 3(1):8\u201314","journal-title":"Heart Rhythm O2"},{"issue":"24","key":"359_CR25","doi-asserted-by":"publisher","first-page":"e023235","DOI":"10.1161\/JAHA.121.023235","volume":"10","author":"I Hernandez","year":"2021","unstructured":"Hernandez I, Gabriel N, He M et al (2021) COVID-19 and anticoagulation for atrial fibrillation: an analysis of us nationwide pharmacy claims data. J Am Heart Assoc 10(24):e023235","journal-title":"J Am Heart Assoc"},{"key":"359_CR26","first-page":"350","volume":"63","author":"KC Poh","year":"2020","unstructured":"Poh KC, Tay VYJ, Lin SHX, Chee H, Suhitharan T (2020) A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population. Singap Med J 63:350\u2013361","journal-title":"Singap Med J"},{"issue":"1","key":"359_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s42444-022-00065-z","volume":"23","author":"S Rafaqat","year":"2022","unstructured":"Rafaqat S, Rafaqat S, Khurshid H, Rafaqat S (2022) Electrolyte\u2019s imbalance role in atrial fibrillation: pharmacological management. Int J Arrhythmia 23(1):15","journal-title":"Int J Arrhythmia"},{"issue":"3","key":"359_CR28","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.hrthm.2015.12.005","volume":"13","author":"Y-Y Lu","year":"2016","unstructured":"Lu Y-Y, Cheng C-C, Chen Y-C et al (2016) Electrolyte disturbances differentially regulate sinoatrial node and pulmonary vein electrical activity: a contribution to hypokalemia- or hyponatremia-induced atrial fibrillation. Heart Rhythm 13(3):781\u2013788","journal-title":"Heart Rhythm"},{"issue":"10","key":"359_CR29","doi-asserted-by":"publisher","first-page":"e007213","DOI":"10.1161\/CIRCEP.119.007213","volume":"12","author":"PG Platonov","year":"2019","unstructured":"Platonov PG, McNitt S, Polonsky B, Rosero SZ, Zareba W (2019) Atrial fibrillation in long QT syndrome by genotype. Circ Arrhythmia Electrophysiol 12(10):e007213","journal-title":"Circ Arrhythmia Electrophysiol"},{"issue":"10","key":"359_CR30","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.hrthm.2013.07.023","volume":"10","author":"MC Mandyam","year":"2013","unstructured":"Mandyam MC, Soliman EZ, Alonso A et al (2013) The QT interval and risk of incident atrial fibrillation. Heart Rhythm 10(10):1562\u20131568","journal-title":"Heart Rhythm"},{"issue":"1","key":"359_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.047293","volume":"142","author":"PE Lazzerini","year":"2020","unstructured":"Lazzerini PE, Boutjdir M, Capecchi PL (2020) COVID-19, arrhythmic risk, and inflammation. Circulation 142(1):7\u20139","journal-title":"Circulation"},{"issue":"1","key":"359_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s42444-020-00017-5","volume":"21","author":"M Hong","year":"2020","unstructured":"Hong M, Chun K-H, Hwang I et al (2020) Clinical and genetic relationships between the QTc interval and risk of a stroke among atrial fibrillation patients undergoing catheter ablation. Int J Arrhythmia 21(1):9","journal-title":"Int J Arrhythmia"},{"issue":"9","key":"359_CR33","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1161\/CIRCRESAHA.114.303772","volume":"114","author":"P-S Chen","year":"2014","unstructured":"Chen P-S, Chen LS, Fishbein MC, Lin S-F, Nattel S (2014) Role of the autonomic nervous system in atrial fibrillation. Circ Res 114(9):1500\u20131515","journal-title":"Circ Res"},{"key":"359_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fcvm.2020.00062","volume":"7","author":"X Zhou","year":"2020","unstructured":"Zhou X, Dudley SC (2020) Evidence for inflammation as a driver of atrial fibrillation. Front Cardiovasc Med 7:62","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"359_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jjcc.2008.09.008","volume":"53","author":"H Ichiki","year":"2009","unstructured":"Ichiki H, Orihara K, Hamasaki S et al (2009) The role of infection in the development of non-valvular atrial fibrillation: up-regulation of Toll-like receptor 2 expression levels on monocytes. J Cardiol 53(1):127\u2013135","journal-title":"J Cardiol"},{"issue":"6","key":"359_CR36","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.hrthm.2016.01.026","volume":"13","author":"T-Y Chang","year":"2016","unstructured":"Chang T-Y, Chao T-F, Liu C-J et al (2016) The association between influenza infection, vaccination, and atrial fibrillation: a nationwide case-control study. Heart Rhythm 13(6):1189\u20131194","journal-title":"Heart Rhythm"},{"key":"359_CR37","first-page":"101106","volume":"42","author":"A Bolton","year":"2022","unstructured":"Bolton A, Thyagaturu H, Ashraf M, Carnahan R, Hodgson-Zingman D (2022) Effects of atrial fibrillation on outcomes of influenza hospitalization. Int J Cardiol Heart Vasc 42:101106","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"5","key":"359_CR38","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/CIRCRESAHA.120.318511","volume":"128","author":"Y-H Lin","year":"2021","unstructured":"Lin Y-H, Platt MP, Gilley RP et al (2021) Influenza causes MLKL-driven cardiac proteome remodeling during convalescence. Circ Res 128(5):570\u2013584","journal-title":"Circ Res"},{"issue":"5","key":"359_CR39","first-page":"176","volume":"23","author":"A Maisano","year":"2022","unstructured":"Maisano A, Vitolo M, Imberti JF et al (2022) Atrial fibrillation in the setting of acute pneumonia: not a secondary arrhythmia. RCM 23(5):176","journal-title":"RCM"},{"issue":"3","key":"359_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/biom8030066","volume":"8","author":"G Aarabi","year":"2018","unstructured":"Aarabi G, Schnabel RB, Heydecke G, Seedorf U (2018) Potential impact of oral inflammations on cardiac functions and atrial fibrillation. Biomolecules 8(3):66","journal-title":"Biomolecules"},{"issue":"13","key":"359_CR41","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.ehj.2004.05.012","volume":"25","author":"A Baba","year":"2004","unstructured":"Baba A, Yoshikawa T, Fukuda Y et al (2004) Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur Heart J 25(13):1108\u20131115","journal-title":"Eur Heart J"},{"issue":"14","key":"359_CR42","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jacc.2009.07.015","volume":"54","author":"S Stavrakis","year":"2009","unstructured":"Stavrakis S, Yu X, Patterson E et al (2009) Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves\u2019 hyperthyroidism. J Am Coll Cardiol 54(14):1309\u20131316","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"359_CR43","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1161\/01.CIR.0000136825.96029.A5","volume":"110","author":"K Mandal","year":"2004","unstructured":"Mandal K, Jahangiri M, Mukhin M et al (2004) Association of anti-heat shock protein 65 antibodies with development of postoperative atrial fibrillation. Circulation 110(17):2588\u20132590","journal-title":"Circulation"},{"issue":"6","key":"359_CR44","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/cvr\/27.6.1045","volume":"27","author":"AY Bagrov","year":"1993","unstructured":"Bagrov AY, Fedorova OV, Roukoyatkina NI, Zhabko EP (1993) Effect of endogenous digoxin-like factor and digoxin antibody on myocardial Na+, K+-pump activity and ventricular arrhythmias in acute myocardial ischaemia in rats. Cardiovasc Res 27(6):1045\u20131050","journal-title":"Cardiovasc Res"},{"issue":"6","key":"359_CR45","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/j.1540-8167.1998.tb00942.x","volume":"9","author":"JM Maixent","year":"1998","unstructured":"Maixent JM, Paganelli F, Scaglione J, Levy S (1998) Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 9(6):612\u2013617","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"11","key":"359_CR46","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.hrthm.2011.06.032","volume":"8","author":"HC Lee","year":"2011","unstructured":"Lee HC, Huang KT, Wang XL, Shen WK (2011) Autoantibodies and cardiac arrhythmias. Heart Rhythm 8(11):1788\u20131795","journal-title":"Heart Rhythm"},{"issue":"18","key":"359_CR47","doi-asserted-by":"publisher","first-page":"e015977","DOI":"10.1161\/JAHA.120.015977","volume":"9","author":"RM Melduni","year":"2020","unstructured":"Melduni RM, Cooper LT, Gersh BJ et al (2020) Association of autoimmune vasculitis and incident atrial fibrillation: a population-based case-control study. J Am Heart Assoc 9(18):e015977","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"359_CR48","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000149151","volume":"112","author":"M Fu","year":"2009","unstructured":"Fu M (2009) Autoantibodies in atrial fibrillation: actors, biomarkers or bystanders? How far have we come? Cardiology 112(3):178","journal-title":"Cardiology"},{"issue":"8","key":"359_CR49","first-page":"17569","volume":"13","author":"I Nouskas","year":"2021","unstructured":"Nouskas I, Holeva V, Parlapani E et al (2021) A COVID-19 patient presenting with paroxysmal atrial fibrillation. Cureus 13(8):17569","journal-title":"Cureus"},{"issue":"4","key":"359_CR50","first-page":"e23912","volume":"14","author":"D Shah","year":"2022","unstructured":"Shah D, Umar Z, Ilyas U et al (2022) New-onset atrial fibrillation in COVID-19 infection: a case report and review of literature. Cureus 14(4):e23912","journal-title":"Cureus"},{"issue":"11","key":"359_CR51","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1016\/j.radcr.2021.07.090","volume":"16","author":"A Bouchlarhem","year":"2021","unstructured":"Bouchlarhem A, Haddar L, Nasri S et al (2021) Brainstem stroke: a fatal thromboembolic event after new onset atrial fibrillation during covid-19 infection: a case report and literature review. Radiol Case Rep 16(11):3244\u20133249","journal-title":"Radiol Case Rep"},{"issue":"5","key":"359_CR52","first-page":"e8054","volume":"12","author":"J Harhay","year":"2020","unstructured":"Harhay J, Khan M, Shah S, Malhotra A (2020) SARS-COV-2 PRESENTING AS NEW ONSET ATRIAL FIBRILLATION: A Case Report. Cureus 12(5):e8054","journal-title":"Cureus"},{"issue":"1","key":"359_CR53","first-page":"e12917","volume":"13","author":"O Al-Abbas","year":"2021","unstructured":"Al-Abbas O, Alshaikhli A, Amran HA (2021) New-onset atrial fibrillation and multiple systemic emboli in a COVID-19 patient. Cureus 13(1):e12917","journal-title":"Cureus"},{"issue":"11","key":"359_CR54","first-page":"e31216","volume":"14","author":"H Mann","year":"2022","unstructured":"Mann H, Chaudry A, Dolkar T, Dufresne A (2022) Coronavirus disease 2019 associated acute myocardial infarction and atrial fibrillation: a case report. Cureus 14(11):e31216","journal-title":"Cureus"},{"issue":"7","key":"359_CR55","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","volume":"26","author":"A Gupta","year":"2020","unstructured":"Gupta A, Madhavan MV, Sehgal K et al (2020) Extrapulmonary manifestations of COVID-19. Nat Med 26(7):1017\u20131032","journal-title":"Nat Med"},{"issue":"8","key":"359_CR56","first-page":"e17569","volume":"13","author":"I Nouskas","year":"2021","unstructured":"Nouskas I, Holeva V, Parlapani E, Nikopoulou VA, Diakogiannis I (2021) A COVID-19 patient presenting with paroxysmal atrial fibrillation. Cureus 13(8):e17569","journal-title":"Cureus"},{"issue":"Fi1","key":"359_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa166","volume":"4","author":"S Schnaubelt","year":"2020","unstructured":"Schnaubelt S, Breyer MK, Siller-Matula J, Domanovits H (2020) Atrial fibrillation: a risk factor for unfavourable outcome in COVID-19? A case report. Eur Heart J Case Rep 4(Fi1):1\u20136","journal-title":"Eur Heart J Case Rep"},{"issue":"2","key":"359_CR58","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1017\/S1047951120003893","volume":"31","author":"AD Santi","year":"2021","unstructured":"Santi AD, Aquino P, Dorfman M (2021) Atrial fibrillation in a child with COVID-19 infection. Cardiol Young 31(2):318\u2013321","journal-title":"Cardiol Young"},{"key":"359_CR59","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jelectrocard.2020.10.004","volume":"73","author":"U Kohli","year":"2022","unstructured":"Kohli U, Meinert E, Chong G, Tesher M, Jani P (2022) Fulminant myocarditis and atrial fibrillation in child with acute COVID-19. J Electrocardiol 73:150\u2013152","journal-title":"J Electrocardiol"},{"key":"359_CR60","doi-asserted-by":"publisher","first-page":"e933163","DOI":"10.12659\/AJCR.933163","volume":"22","author":"S Hajouli","year":"2021","unstructured":"Hajouli S (2021) A 29-year-old man with COVID-19 pneumonia, heart failure-reduced ejection fraction, and atrial fibrillation with a father and 2 grandparents who were positive for SARS-CoV-2 infection. Am J Case Rep 22:e933163","journal-title":"Am J Case Rep"},{"key":"359_CR61","doi-asserted-by":"crossref","first-page":"232470962092557","DOI":"10.1177\/2324709620925571","volume":"8","author":"R Seecheran","year":"2020","unstructured":"Seecheran R, Narayansingh R, Giddings S et al (2020) Atrial arrhythmias in a patient presenting with coronavirus disease-2019 (COVID-19) infection. J Investig Med High Impact Case Rep 8:2324709620925571","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"5","key":"359_CR62","first-page":"e8066","volume":"12","author":"ME Taha","year":"2020","unstructured":"Taha ME, Alsafi W, Taha M, Eljack A, Ibrahim H (2020) Coronavirus disease and new-onset atrial fibrillation: two cases. Cureus 12(5):e8066","journal-title":"Cureus"},{"key":"359_CR63","doi-asserted-by":"publisher","first-page":"101127","DOI":"10.1016\/j.ijcha.2022.101127","volume":"43","author":"MJ Cutler","year":"2022","unstructured":"Cutler MJ, May HT, Bair TL et al (2022) Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19. IJC Heart Vasc 43:101127","journal-title":"IJC Heart Vasc"},{"issue":"14","key":"359_CR64","doi-asserted-by":"publisher","first-page":"e017529","DOI":"10.1161\/JAHA.120.017529","volume":"9","author":"P Rattanawong","year":"2020","unstructured":"Rattanawong P, Shen W, Masry HE et al (2020) Guidance on short-term management of atrial fibrillation in coronavirus disease 2019. J Am Heart Assoc 9(14):e017529","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"359_CR65","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1253\/circj.CJ-20-0566","volume":"84","author":"Y-F Hu","year":"2020","unstructured":"Hu Y-F, Cheng W-H, Hung Y et al (2020) Management of atrial fibrillation in COVID-19 pandemic. Circ J 84(10):1679\u20131685","journal-title":"Circ J"},{"issue":"21","key":"359_CR66","doi-asserted-by":"publisher","first-page":"e823","DOI":"10.1161\/CIRCULATIONAHA.120.047063","volume":"141","author":"DR Lakkireddy","year":"2020","unstructured":"Lakkireddy DR, Chung MK, Gopinathannair R et al (2020) Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. Circulation 141(21):e823\u2013e831","journal-title":"Circulation"},{"issue":"1","key":"359_CR67","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10840-021-00952-w","volume":"63","author":"CR Barbhaiya","year":"2022","unstructured":"Barbhaiya CR, Wadhwani L, Manmadhan A et al (2022) Rebooting atrial fibrillation ablation in the COVID-19 pandemic. J Interv Card Electrophysiol 63(1):97\u2013101","journal-title":"J Interv Card Electrophysiol"},{"issue":"6","key":"359_CR68","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1002\/ehf2.13009","volume":"7","author":"K Li","year":"2020","unstructured":"Li K, Qin M, Jiang W et al (2020) Management of catheter ablation in arrhythmia patients during the coronavirus disease 2019 epidemic. ESC Heart Fail 7(6):4032\u20134039","journal-title":"ESC Heart Fail"},{"issue":"1","key":"359_CR69","doi-asserted-by":"publisher","first-page":"e001969","DOI":"10.1136\/openhrt-2022-001969","volume":"9","author":"C Pius","year":"2022","unstructured":"Pius C, Ahmad H, Snowdon R et al (2022) Impact of COVID-19 on patients awaiting ablation for atrial fibrillation. Open Heart 9(1):e001969","journal-title":"Open Heart"},{"issue":"12","key":"359_CR70","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/crj.13438","volume":"15","author":"M Sarkar","year":"2021","unstructured":"Sarkar M, Madabhavi IV, Quy PN, Govindagoudar MB (2021) COVID-19 and coagulopathy. Clin Respir J 15(12):1259\u20131274","journal-title":"Clin Respir J"},{"key":"359_CR71","doi-asserted-by":"publisher","first-page":"769254","DOI":"10.3389\/fphys.2021.769254","volume":"12","author":"FJ Gonzalez-Gonzalez","year":"2021","unstructured":"Gonzalez-Gonzalez FJ, Ziccardi MR, McCauley MD (2021) Virchow\u2019s triad and the role of thrombosis in COVID-related stroke. Front Physiol 12:769254","journal-title":"Front Physiol"},{"issue":"6","key":"359_CR72","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1161\/CIRCEP.112.979229","volume":"5","author":"F Violi","year":"2012","unstructured":"Violi F, Loffredo L (2012) Thromboembolism or atherothromboembolism in atrial fibrillation? Circ Arrhythmia Electrophysiol 5(6):1053\u20131055","journal-title":"Circ Arrhythmia Electrophysiol"},{"issue":"6","key":"359_CR73","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/CIRCEP.114.001356","volume":"7","author":"P Zimetbaum","year":"2014","unstructured":"Zimetbaum P, Waks JW, Ellis ER, Glotzer TV, Passman RS (2014) Role of atrial fibrillation burden in assessing thromboembolic risk. Circ Arrhythmia Electrophysiol 7(6):1223\u20131229","journal-title":"Circ Arrhythmia Electrophysiol"},{"issue":"2","key":"359_CR74","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","volume":"366","author":"JS Healey","year":"2012","unstructured":"Healey JS, Connolly SJ, Gold MR et al (2012) Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 366(2):120\u2013129","journal-title":"N Engl J Med"},{"issue":"1","key":"359_CR75","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/heartjnl-2019-314898","volume":"106","author":"S Jame","year":"2020","unstructured":"Jame S, Barnes G (2020) Stroke and thromboembolism prevention in atrial fibrillation. Heart 106(1):10\u201317","journal-title":"Heart"},{"key":"359_CR76","first-page":"1","volume":"36","author":"AI Qureshi","year":"2021","unstructured":"Qureshi AI, Baskett WI, Huang W et al (2021) Intracerebral hemorrhage and coronavirus disease 2019 in a cohort of 282,718 hospitalized patients. Neurocrit Care 36:1\u20137","journal-title":"Neurocrit Care"},{"issue":"1","key":"359_CR77","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1161\/STROKEAHA.120.031668","volume":"52","author":"MS Dhamoon","year":"2021","unstructured":"Dhamoon MS, Thaler A, Gururangan K et al (2021) Acute cerebrovascular events with COVID-19 infection. Stroke 52(1):48\u201356","journal-title":"Stroke"},{"issue":"1","key":"359_CR78","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/19714009211029177","volume":"35","author":"B Bahranifard","year":"2022","unstructured":"Bahranifard B, Mehdizadeh S, Hamidi A et al (2022) A review of neuroradiological abnormalities in patients with coronavirus disease 2019 (COVID-19). Neuroradiol J 35(1):3\u201324","journal-title":"Neuroradiol J"},{"issue":"4","key":"359_CR79","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/jth.13974","volume":"16","author":"PL Lutsey","year":"2018","unstructured":"Lutsey PL, Norby FL, Alonso A et al (2018) Atrial fibrillation and venous thromboembolism: evidence of bidirectionality in the atherosclerosis risk in communities study. J Thromb Haemost 16(4):670\u2013679","journal-title":"J Thromb Haemost"},{"issue":"12","key":"359_CR80","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1093\/europace\/euab180","volume":"23","author":"B Hornestam","year":"2021","unstructured":"Hornestam B, Adiels M, Wai Giang K et al (2021) Atrial fibrillation and risk of venous thromboembolism: a Swedish Nationwide Registry Study. EP Europace 23(12):1913\u20131921","journal-title":"EP Europace"},{"key":"359_CR81","doi-asserted-by":"publisher","first-page":"7846291","DOI":"10.1155\/2019\/7846291","volume":"2019","author":"K Ptaszynska-Kopczynska","year":"2019","unstructured":"Ptaszynska-Kopczynska K, Kiluk I, Sobkowicz B (2019) Atrial fibrillation in patients with acute pulmonary embolism: clinical significance and impact on prognosis. Biomed Res Int 2019:7846291","journal-title":"Biomed Res Int"},{"issue":"2","key":"359_CR82","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1067\/mje.2001.108668","volume":"14","author":"M Bashir","year":"2001","unstructured":"Bashir M, Asher CR, Garcia MJ et al (2001) Right atrial spontaneous echo contrast and thrombi in atrial fibrillation: a transesophageal echocardiography study. J Am Soc Echocardiogr 14(2):122\u2013127","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"359_CR83","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1177\/1076029608323088","volume":"16","author":"O Ozer","year":"2010","unstructured":"Ozer O, Sari I, Davutoglu V (2010) Right atrial appendage: forgotten part of the heart in atrial fibrillation. Clin Appl Thromb Hemost 16(2):218\u2013220","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1\u20136","key":"359_CR84","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.0954-6820.1969.tb07351.x","volume":"185","author":"H Aberg","year":"1969","unstructured":"Aberg H (1969) Atrial fibrillation: I. A study of atrial thrombosis and systemic embolism in a necropsy material. Acta Med Scand 185(1\u20136):373\u2013379","journal-title":"Acta Med Scand"},{"issue":"1","key":"359_CR85","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12931-023-02369-7","volume":"24","author":"MH Gul","year":"2023","unstructured":"Gul MH, Htun ZM, de Jesus Perez V et al (2023) Predictors and outcomes of acute pulmonary embolism in COVID-19; insights from US National COVID cohort collaborative. Respir Res 24(1):59","journal-title":"Respir Res"},{"key":"359_CR86","doi-asserted-by":"publisher","first-page":"100639","DOI":"10.1016\/j.eclinm.2020.100639","volume":"29","author":"MB Malas","year":"2020","unstructured":"Malas MB, Naazie IN, Elsayed N et al (2020) Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis. EClinicalMedicine 29:100639","journal-title":"EClinicalMedicine"},{"issue":"4","key":"359_CR87","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/emermed-2012-202089","volume":"31","author":"SNC Barra","year":"2014","unstructured":"Barra SNC, Paiva LV, Provid\u00eancia R, Fernandes A, Leit\u00e3o Marques A (2014) Atrial fibrillation in acute pulmonary embolism: prognostic considerations. Emerg Med J 31(4):308\u2013312","journal-title":"Emerg Med J"},{"issue":"1","key":"359_CR88","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12872-019-1081-8","volume":"19","author":"MA Abdulsalam","year":"2019","unstructured":"Abdulsalam MA, Elganainy MN, Abdulsalam AJ (2019) Pulmonary embolism causing atrial fibrillation with slow ventricular response: a case report. BMC Cardiovasc Disord 19(1):101","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"359_CR89","doi-asserted-by":"publisher","first-page":"18111","DOI":"10.1038\/s41598-021-97335-y","volume":"11","author":"YG Kim","year":"2021","unstructured":"Kim YG, Choi YY, Han K-D et al (2021) Atrial fibrillation is associated with increased risk of lethal ventricular arrhythmias. Sci Rep 11(1):18111","journal-title":"Sci Rep"},{"issue":"21","key":"359_CR90","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1161\/CIRCULATIONAHA.115.018891","volume":"132","author":"A Sarrias","year":"2015","unstructured":"Sarrias A, Villuendas R, Bisbal F et al (2015) From atrial fibrillation to ventricular fibrillation and back. Circulation 132(21):2035\u20132036","journal-title":"Circulation"},{"issue":"3","key":"359_CR91","doi-asserted-by":"publisher","first-page":"e023473","DOI":"10.1161\/JAHA.121.023473","volume":"11","author":"CB Ingul","year":"2022","unstructured":"Ingul CB, Grimsmo J, Mecinaj A et al (2022) Cardiac dysfunction and arrhythmias 3 months after hospitalization for COVID-19. J Am Heart Assoc 11(3):e023473","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"359_CR92","doi-asserted-by":"publisher","first-page":"153","DOI":"10.15420\/aer.2017\/6.4\/EO1","volume":"6","author":"DJ Callans","year":"2017","unstructured":"Callans DJ (2017) Premature ventricular contraction-induced cardiomyopathy. Arrhythm Electrophysiol Rev 6(4):153\u2013155","journal-title":"Arrhythm Electrophysiol Rev"},{"issue":"Suppl F","key":"359_CR93","doi-asserted-by":"publisher","first-page":"suab125.063","DOI":"10.1093\/eurheartjsupp\/suab125.063","volume":"23","author":"B Jeremiah","year":"2021","unstructured":"Jeremiah B, Lubis AC, Hasan H (2021) C64. New ONSET PVC bigeminy post Covid-19 infection: another covid-cardiac related problem. Eur Heart J Suppl. 2021;23(Suppl F):suab125.063","journal-title":"Eur Heart J Suppl."},{"key":"359_CR94","doi-asserted-by":"publisher","first-page":"100867","DOI":"10.1016\/j.nmni.2021.100867","volume":"41","author":"E Mohammadyari","year":"2021","unstructured":"Mohammadyari E, Ahmadi I, Mohammadyari A, Tavan H, Norozi S (2021) The frequency of arrhythmias in COVID-19 patients, a study in the Shahid Mostafa Khomeini Hospital of Ilam from March to August 2020. New Microbes New Infect 41:100867","journal-title":"New Microbes New Infect"},{"issue":"3","key":"359_CR95","doi-asserted-by":"publisher","first-page":"e009458","DOI":"10.1161\/CIRCEP.120.009458","volume":"14","author":"EJ Coromilas","year":"2021","unstructured":"Coromilas EJ, Kochav S, Goldenthal I et al (2021) Worldwide survey of COVID-19-associated arrhythmias. Circ Arrhythm Electrophysiol 14(3):e009458","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"12","key":"359_CR96","doi-asserted-by":"publisher","first-page":"e0244533","DOI":"10.1371\/journal.pone.0244533","volume":"15","author":"JH Cho","year":"2021","unstructured":"Cho JH, Namazi A, Shelton R et al (2021) Cardiac arrhythmias in hospitalized patients with COVID-19: a prospective observational study in the western United States. PLoS ONE 15(12):e0244533","journal-title":"PLoS ONE"},{"issue":"9","key":"359_CR97","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jacc.2020.01.036","volume":"75","author":"G Peretto","year":"2020","unstructured":"Peretto G, Sala S, Rizzo S et al (2020) Ventricular arrhythmias in myocarditis: characterization and relationships with myocardial inflammation. J Am Coll Cardiol 75(9):1046\u20131057","journal-title":"J Am Coll Cardiol"},{"issue":"FI1","key":"359_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa217","volume":"4","author":"G Mitacchione","year":"2020","unstructured":"Mitacchione G, Schiavone M, Gasperetti A, Forleo GB (2020) Ventricular tachycardia storm management in a COVID-19 patient: a case report. Eur Heart J Case Rep 4(FI1):1\u20136","journal-title":"Eur Heart J Case Rep"},{"issue":"1","key":"359_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10840-022-01263-4","volume":"65","author":"A Kumar","year":"2022","unstructured":"Kumar A, Shariff M, Bhat V, DeSimone C, Deshmukh A (2022) Atrial fibrillation after vaccination for COVID-19: analysis of the vaccine adverse event reporting system. J Interv Card Electrophysiol 65(1):1\u20132","journal-title":"J Interv Card Electrophysiol"},{"issue":"1","key":"359_CR100","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/vaccines11010112","volume":"11","author":"MH Abutaleb","year":"2023","unstructured":"Abutaleb MH, Makeen HA, Meraya AM et al (2023) Risks of cardiac arrhythmia associated with COVID-19 vaccination: a systematic review and meta-analysis. Vaccines (Basel) 11(1):112","journal-title":"Vaccines (Basel)"},{"key":"359_CR101","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2147\/RMHP.S402007","volume":"16","author":"CY Chen","year":"2023","unstructured":"Chen CY, Hsieh M, Wei CT, Lin CW (2023) Atrial fibrillation after mRNA-1273 SARS-CoV-2 vaccination: case report with literature review. Risk Manag Healthc Policy 16:209\u2013214","journal-title":"Risk Manag Healthc Policy"},{"key":"359_CR102","doi-asserted-by":"publisher","first-page":"175628642210947","DOI":"10.1177\/17562864221094714","volume":"15","author":"A Theodorou","year":"2022","unstructured":"Theodorou A, Bakola E, Chondrogianni M et al (2022) Covid-vaccine-fear-induced paroxysmal atrial fibrillation causing multiple acute arterial infarctions: a case report. Ther Adv Neurol Disord 15:17562864221094714","journal-title":"Ther Adv Neurol Disord"},{"issue":"Suppl_1","key":"359_CR103","first-page":"A10638","volume":"146","author":"GA Vargas","year":"2022","unstructured":"Vargas GA, Azarbal JR, Tang F, Hammel IS (2022) Abstract 10638: the effectiveness of Covid 19 vaccines against new onset atrial fibrillation in hospitalized Covid 19 patients. Circulation 146(Suppl_1):A10638\u2013A10638","journal-title":"Circulation"},{"issue":"5","key":"359_CR104","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jacep.2017.03.002","volume":"3","author":"S Nattel","year":"2017","unstructured":"Nattel S (2017) Molecular and cellular mechanisms of atrial\u00a0fibrosis in atrial\u00a0fibrillation. JACC Clin Electrophysiol 3(5):425\u2013435","journal-title":"JACC Clin Electrophysiol"},{"issue":"8","key":"359_CR105","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jacc.2007.09.064","volume":"51","author":"B Burstein","year":"2008","unstructured":"Burstein B, Nattel S (2008) Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 51(8):802\u2013809","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"359_CR106","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1161\/CIRCRESAHA.116.305326","volume":"116","author":"X-Y Qi","year":"2015","unstructured":"Qi X-Y, Huang H, Ordog B et al (2015) Fibroblast inward-rectifier potassium current upregulation in profibrillatory atrial remodeling. Circ Res 116(5):836\u2013845","journal-title":"Circ Res"},{"issue":"7224","key":"359_CR107","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nature07511","volume":"456","author":"T Thum","year":"2008","unstructured":"Thum T, Gross C, Fiedler J et al (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456(7224):980\u2013984","journal-title":"Nature"},{"issue":"3","key":"359_CR108","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1161\/HYPERTENSIONAHA.107.098459","volume":"51","author":"ER Olson","year":"2008","unstructured":"Olson ER, Shamhart PE, Naugle JE, Meszaros JG (2008) Angiotensin II-induced extracellular signal-regulated kinase 1\/2 activation is mediated by protein kinase C\u03b4 and intracellular calcium in adult rat cardiac fibroblasts. Hypertension 51(3):704\u2013711","journal-title":"Hypertension"},{"issue":"8","key":"359_CR109","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1161\/CIRCRESAHA.110.227421","volume":"107","author":"C Vasquez","year":"2010","unstructured":"Vasquez C, Mohandas P, Louie KL et al (2010) Enhanced fibroblast-myocyte interactions in response to cardiac injury. Circ Res 107(8):1011\u20131020","journal-title":"Circ Res"},{"issue":"4","key":"359_CR110","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/cvr\/cvq329","volume":"89","author":"L Yue","year":"2011","unstructured":"Yue L, Xie J, Nattel S (2011) Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res 89(4):744\u2013753","journal-title":"Cardiovasc Res"},{"issue":"9","key":"359_CR111","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1529\/biophysj.108.136473","volume":"95","author":"S Zlochiver","year":"2008","unstructured":"Zlochiver S, Munoz V, Vikstrom KL et al (2008) Electrotonic myofibroblast-to-myocyte coupling increases propensity to reentrant arrhythmias in two-dimensional cardiac monolayers. Biophys J 95(9):4469\u20134480","journal-title":"Biophys J"},{"issue":"7171","key":"359_CR112","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nature06321","volume":"450","author":"W Roell","year":"2007","unstructured":"Roell W, Lewalter T, Sasse P et al (2007) Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 450(7171):819\u2013824","journal-title":"Nature"},{"issue":"6","key":"359_CR113","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","volume":"118","author":"JG Travers","year":"2016","unstructured":"Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC (2016) Cardiac fibrosis. Circ Res 118(6):1021\u20131040","journal-title":"Circ Res"},{"issue":"1","key":"359_CR114","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1172\/JCI39942","volume":"120","author":"C-H Liao","year":"2010","unstructured":"Liao C-H, Akazawa H, Tamagawa M et al (2010) Cardiac mast cells cause atrial fibrillation through PDGF-A\u2013mediated fibrosis in pressure-overloaded mouse hearts. J Clin Investig 120(1):242\u2013253","journal-title":"J Clin Investig"},{"key":"359_CR115","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fcvm.2020.00150","volume":"7","author":"L Song","year":"2020","unstructured":"Song L, Zhao S, Wang L et al (2020) Cardiovascular changes in patients with COVID-19 from Wuhan, China. Front Cardiovasc Med 7:150","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"359_CR116","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrcardio.2012.158","volume":"10","author":"KT Weber","year":"2013","unstructured":"Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC (2013) Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol 10(1):15\u201326","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"359_CR117","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1161\/CIRCRESAHA.111.244798","volume":"109","author":"C Rosker","year":"2011","unstructured":"Rosker C, Salvarani N, Schmutz S, Grand T, Rohr S (2011) Abolishing myofibroblast arrhythmogeneicity by pharmacological ablation of \u03b1-smooth muscle actin containing stress fibers. Circ Res 109(10):1120\u20131131","journal-title":"Circ Res"},{"issue":"4","key":"359_CR118","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/cvr\/cvq329","volume":"89","author":"L Yue","year":"2010","unstructured":"Yue L, Xie J, Nattel S (2010) Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res 89(4):744\u2013753","journal-title":"Cardiovasc Res"},{"issue":"10","key":"359_CR119","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s00018-008-7408-8","volume":"65","author":"CS Lin","year":"2008","unstructured":"Lin CS, Pan CH (2008) Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation. Cell Mol Life Sci 65(10):1489\u20131508","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"359_CR120","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0008-6363(98)00297-1","volume":"42","author":"YY Li","year":"1999","unstructured":"Li YY, McTiernan CF, Feldman AM (1999) Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells. Cardiovasc Res 42(1):162\u2013172","journal-title":"Cardiovasc Res"},{"issue":"12","key":"359_CR121","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1161\/01.RES.86.12.1259","volume":"86","author":"DA Siwik","year":"2000","unstructured":"Siwik DA, Chang DL, Colucci WS (2000) Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 86(12):1259\u20131265","journal-title":"Circ Res"},{"issue":"2","key":"359_CR122","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.cardiores.2006.03.016","volume":"71","author":"CE Murdoch","year":"2006","unstructured":"Murdoch CE, Zhang M, Cave AC, Shah AM (2006) NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc Res 71(2):208\u2013215","journal-title":"Cardiovasc Res"},{"issue":"1","key":"359_CR123","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1023\/B:HREV.0000011393.40674.13","volume":"9","author":"DA Siwik","year":"2004","unstructured":"Siwik DA, Colucci WS (2004) Regulation of matrix metalloproteinases by cytokines and reactive oxygen\/nitrogen species in the myocardium. Heart Fail Rev 9(1):43\u201351","journal-title":"Heart Fail Rev"},{"issue":"23","key":"359_CR124","doi-asserted-by":"publisher","first-page":"12746","DOI":"10.1073\/pnas.97.23.12746","volume":"97","author":"YY Li","year":"2000","unstructured":"Li YY, Feng YQ, Kadokami T et al (2000) Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Proc Natl Acad Sci U S A 97(23):12746\u201312751","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"359_CR125","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev.pharmtox.47.120505.105230","volume":"47","author":"R Schulz","year":"2007","unstructured":"Schulz R (2007) Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches. Annu Rev Pharmacol Toxicol 47(1):211\u2013242","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"359_CR126","doi-asserted-by":"publisher","first-page":"C53","DOI":"10.1152\/ajpcell.2001.280.1.C53","volume":"280","author":"DA Siwik","year":"2001","unstructured":"Siwik DA, Pagano PJ, Colucci WS (2001) Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 280(1):C53-60","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"359_CR127","first-page":"391","volume":"28","author":"A Yabluchanskiy","year":"2013","unstructured":"Yabluchanskiy A, Ma Y, Iyer RP, Hall ME, Lindsey ML (2013) Matrix metalloproteinase-9: many shades of function in cardiovascular disease. Physiology (Bethesda) 28(6):391\u2013403","journal-title":"Physiology (Bethesda)"},{"issue":"1","key":"359_CR128","first-page":"45","volume":"85","author":"H Zhu","year":"2005","unstructured":"Zhu H, Zhang W, Guo CH et al (2005) Effects of matrix metalloproteinase-9 and tissue inhibitor-1 of metalloproteinase expression on atrial structural remodeling during chronic atrial fibrillation. Zhonghua Yi Xue Za Zhi 85(1):45\u201348","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"5","key":"359_CR129","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.jacc.2003.08.060","volume":"43","author":"Y Nakano","year":"2004","unstructured":"Nakano Y, Niida S, Dote K et al (2004) Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation. J Am Coll Cardiol 43(5):818\u2013825","journal-title":"J Am Coll Cardiol"},{"issue":"Pt 12","key":"359_CR130","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1242\/jcs.113.12.2319","volume":"113","author":"D Nath","year":"2000","unstructured":"Nath D, Slocombe PM, Webster A et al (2000) Meltrin gamma(ADAM-9) mediates cellular adhesion through alpha(6)beta(1)integrin, leading to a marked induction of fibroblast cell motility. J Cell Sci 113(Pt 12):2319\u20132328","journal-title":"J Cell Sci"},{"issue":"24","key":"359_CR131","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1161\/01.CIR.101.24.2854","volume":"101","author":"B Ding","year":"2000","unstructured":"Ding B, Price RL, Goldsmith EC et al (2000) Left ventricular hypertrophy in ascending aortic stenosis mice. Circulation 101(24):2854\u20132862","journal-title":"Circulation"},{"issue":"5392","key":"359_CR132","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1126\/science.282.5392.1281","volume":"282","author":"JJ Peschon","year":"1998","unstructured":"Peschon JJ, Slack JL, Reddy P et al (1998) An essential role for ectodomain shedding in mammalian development. Science 282(5392):1281\u20131284","journal-title":"Science"},{"issue":"6","key":"359_CR133","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/hc0602.103639","volume":"105","author":"M Arndt","year":"2002","unstructured":"Arndt M, Lendeckel U, R\u00f6cken C et al (2002) Altered expression of ADAMs (A Disintegrin And Metalloproteinase) in fibrillating human atria. Circulation 105(6):720\u2013725","journal-title":"Circulation"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-023-00359-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-023-00359-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-023-00359-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T19:44:55Z","timestamp":1702323895000},"score":1,"resource":{"primary":{"URL":"https:\/\/tehj.springeropen.com\/articles\/10.1186\/s43044-023-00359-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,30]]},"references-count":133,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["359"],"URL":"https:\/\/doi.org\/10.1186\/s43044-023-00359-0","relation":{},"ISSN":["2090-911X"],"issn-type":[{"value":"2090-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,30]]},"assertion":[{"value":"28 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}